Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Mesenchymal Stem / Stromal Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • cGMP CliniControl™ Products
      • Human Mesenchymal Stem / Stromal Cells (hMSCs)
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Cold Atmospheric Plasma Selectively Disrupts Breast Cancer Growth in a Bioprinted 3D Tumor Microenvironment Model

December 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Drug Screening, Orthopedic, Tissue Engineering

Expandable, Functional Hepatocytes Derived from Primary Cells Enable Liver Therapeutics

December 2024 Bioprinting, Cell Therapy, Clinical, Drug Screening, Tissue Engineering

The VEGF‐Mediated Cytoprotective Ability of MIF‐Licensed Mesenchymal Stromal Cells in House Dust Mite‐Induced Epithelial Damage

November 2024 Bioprocessing, Cardiovascular, Cell Therapy, Dermal and Wound, Drug Screening, Exosomes / Extracellular Vesicles, Immunomodulation, Lung, Orthopedic

A Streamlined High-Throughput LC-MS Assay for Quantifying Peptide Degradation in Cell Culture

October 2024 Bioprocessing, Cell Therapy, Drug Screening, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials

Nanoscale Titanium and Polycatecholamine Surface Science to Enhance Bone and Uterine Tissue Engineering

October 2024 Bioprinting, Cell Therapy, Drug Screening, MedTech, Devices, & Materials, Tissue Engineering

Paracrine signals influence patterns of fibrocartilage differentiation in a lyophilized gelatin hydrogel for applications in rotator cuff repair

August 2024 Bioprinting, Bioprocessing, Cell Therapy, Drug Screening, MedTech, Devices, & Materials, Tissue Engineering

Donor Sex and Passage Conditions Influence MSC Osteogenic Response in Mineralized Collagen Scaffolds

July 2024 Bioprinting, Bioprocessing, Drug Screening, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

Microglia Morphological Response to Mesenchymal Stromal Cell Extracellular Vesicles Demonstrates EV Therapeutic Potential for Modulating Neuroinflammation

July 2024 Bioprocessing, Cancer, Cell Therapy, Clinical, Drug Screening, Exosomes / Extracellular Vesicles, Immunomodulation

Insights Into Spatiotemporal Dynamics Of Alloreactive T Cell Response with γMSCS Administraion

June 2024 Bioprocessing, Blood, Cell Therapy, Clinical, Drug Screening, Immunomodulation

Mesenchymal Stromal Cell-Derived Extracellular Vesicles Modulate Microglia Morphology and Mitochondrial Content

June 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Clinical, Drug Screening, Exosomes / Extracellular Vesicles, Immunomodulation, Tissue Engineering
1 2 3 4 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Mesenchymal Stem / Stromal Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2025 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email